Copay help by condition · Heart and circulation · read 2026-11-08
Hypercholesterolemia: which charitable copay funds are open
1 fund for Hypercholesterolemia says it is open right now, of the 2 we hold (read 2026-11-08).
Open: Hypercholesterolemia from TotalAssist (Patient Advocate Foundation copay funds). Eligibility is each fund's own rule.
If you have Medicare Part D: CMS prints the annual out-of-pocket threshold as $2,400 in 2027 ($2,100 in 2026) (Table V-2 of its CY 2027 announcement). It is a benefit parameter and applies to covered drugs under plan rules. What changes on January 1.
Swipe to read across
A copy for a patient, a clinic or a pharmacist, with each source and the date we read it.
Every fund we hold for Hypercholesterolemia
- OpenHypercholesterolemia
TotalAssist (Patient Advocate Foundation copay funds) ·
Award level: $3,800Insurance supported: Medicaid, Medicare, TRICARE
The page lists the fund as Open. Source page
- Closed or at capacityHypercholesterolemia - Medicare Access
HealthWell Foundation ·
Award level: not statedInsurance supported: not stated
The page lists the fund as Closed. Source page
Drugs whose FDA label names Hypercholesterolemia
3 drugs. Each row quotes the sentence of the drug's FDA label (Indications and Usage, openFDA) that names the condition. A label naming a condition is not a statement that the drug is approved, effective or covered for you. Dashes in quotes are shown as hyphens. Of these, 2 have a program (in our assistance finder or on the program's own page) and 0 have a Medicare negotiated price in the CMS file; an empty cell says we found nothing in our data, not that nothing exists.
| Drug | What the FDA label says | Manufacturer program | Medicare negotiated price |
|---|---|---|---|
| Praluent Alirocumab Every route for this drug | ... adults with hypercholesterolemia. Label on openFDA, read 2026-11-10 | Heart Medication Assistance (Multiple Programs) | not in the CMS negotiated-price file |
| Repatha Evolocumab Every route for this drug | ... cholesterol (LDL-C)-lowering therapies, in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), to reduce LDL-C As an adjunct to diet and other LDL-C-lowering therapies in pediatric patients aged 10 years ... Label on openFDA, read 2026-11-10 | Repatha Savings (via Amgen) Heart Medication Assistance (Multiple Programs) Amgen Safety Net Foundation (program page) | not in the CMS negotiated-price file |
| Simvastatin Simvastatin | In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). Label on openFDA, read 2026-11-10 | not in our assistance finder | not in the CMS negotiated-price file |
Related conditions
No broader or more specific condition page for this one.
Group: Heart and circulation. All conditions: the condition index. Fund board for every condition: charitable copay fund status.
What changed
First read on 2026-11-08. We keep each read with its date, so a fund reopening or closing will show here as a change. Until we have a second read there is nothing to compare, and we do not guess. The read date of every source is on the changes page.
This page as data
The same facts as JSON, each fund with its source URL and read date: hypercholesterolemia.json. Edition 2026-11, root 006ab9a329709cbe. See the licence page.
Questions
Is there an open charitable copay fund for Hypercholesterolemia?
As read on 2026-11-08, 1 of the 2 funds we hold for Hypercholesterolemia say they are open: Hypercholesterolemia from TotalAssist (Patient Advocate Foundation copay funds). Funds open and close, so check the source page before you apply.
Which organizations run funds for Hypercholesterolemia?
TotalAssist (Patient Advocate Foundation copay funds) and HealthWell Foundation. Each fund row on this page links to the organization's own page.
Does an open fund mean I qualify?
No. A status says whether a fund is taking applications. Eligibility, award level and which insurance it supports are each fund's own rules; where the page states them they are shown on the fund.
How current is this page?
Statuses are what each fund's own page said on the date we read it (2026-11-08). We do not promise a fund is still in that state today.